1-4 of 4
Steven E. Shoelson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139

Allison B. Goldfine, Kathleen A. Jablonski, Steven E. Shoelson, Mark A. Creager, for the TINSAL-FMD (Targeting Inflammation Using Salsalate in Type 2 Diabetes–Flow-Mediated Dilation) Ancillary Study Team
Journal: Diabetes Care
Diabetes Care 2014;37(5):e112
https://doi.org/10.2337/dc14-0222
Published: 10 April 2014
View article titled, Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139
Open the PDF for Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139 in another window
Journal Articles

The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes

Joshua I. Barzilay, Kathleen A. Jablonski, Vivian Fonseca, Steven E. Shoelson, Allison B. Goldfine, Christopher Strauch, Vincent M. Monnier, the TINSAL-T2D Research Consortium
Journal: Diabetes Care
Diabetes Care 2014;37(4):1083–1091
https://doi.org/10.2337/dc13-1527
Published: 08 March 2014
View article titled, The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes
Open the PDF for The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD)

Allison B. Goldfine, MD, J. Stewart Buck, BS, Cyrus Desouza, MD, Vivian Fonseca, MD, Yii-Der Ida Chen, PHD, Steven E. Shoelson, MD, Kathleen A. Jablonski, PHD, Mark A. Creager, MD, for the TINSAL-FMD (Targeting Inflammation Using Salsalate in Type 2 Diabetes–Flow-Mediated Dilation) Ancillary Study Team
Journal: Diabetes Care
Diabetes Care 2013;36(12):4132–4139
https://doi.org/10.2337/dc13-0859
Published: 13 November 2013
View article titled, Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD)
Open the PDF for Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD) in another window
Journal Articles

Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults

Amy Fleischman, MD, MMSC, Steven E. Shoelson, MD, PHD, Raquel Bernier, BS, Allison B. Goldfine, MD
Journal: Diabetes Care
Diabetes Care 2008;31(2):289–294
https://doi.org/10.2337/dc07-1338
Published: 01 February 2008
View article titled, Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults
Open the PDF for Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults in another window